06996.HK
Antengene Corporation Limited
HKSE · Healthcare · Biotechnology · CN
HKD 3.56
−0.70%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 6.13x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.09x
- Price / sales
- 2.97x
- Price / cash flow
- -14.97x
Enterprise value
- Enterprise value
- HKD 1.6B
- EV / sales
- 2.18x
- EV / EBITDA
- -14.89x
- EV / EBIT
- -10.89x
- Market cap
- HKD 2.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026